Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
出版年份 2016 全文链接
标题
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 44, Issue 8, Pages 877-889
出版商
Wiley
发表日期
2016-08-23
DOI
10.1111/apt.13770
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Critical comparison of elastography methods to assess chronic liver disease
- (2016) Mireen Friedrich-Rust et al. Nature Reviews Gastroenterology & Hepatology
- Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B
- (2015) M. Houot et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Assessment of liver fibrosis: The relationship between point shear wave elastography and quantitative histological analysis
- (2015) Hong Ding et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards
- (2015) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort
- (2015) Julia Kälsch et al. Scientific Reports
- Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
- (2015) Thierry Poynard et al. BMJ Open
- Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia
- (2014) H. Perazzo et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis
- (2014) D. T. Chao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)
- (2014) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Liver Biopsy Analysis Has a Low Level of Performance for Diagnosis of Intermediate Stages of Fibrosis
- (2012) Thierry Poynard et al. Clinical Gastroenterology and Hepatology
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
- (2012) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
- (2012) Thierry Poynard et al. PLoS One
- The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases
- (2011) G. Sebastiani et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
- (2011) Thierry Poynard et al. BMC GASTROENTEROLOGY
- Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity
- (2011) Guillaume Lassailly et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease
- (2011) Leon A Adams et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- FibroTest® and Fibroscan® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate
- (2011) Thierry Poynard et al. Clinics and Research in Hepatology and Gastroenterology
- Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
- (2010) Thierry Poynard et al. BMC GASTROENTEROLOGY
- ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure
- (2010) T. Poynard et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve Revisited
- (2008) J. Lambert et al. CLINICAL CHEMISTRY
- Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease
- (2008) Sylvie Naveau et al. HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started